ROVQIX builds websites and platforms for biotech and life sciences organisations — programme and pipeline presentation, searchable publication libraries, investor content and internal research tooling — structured for audiences that read carefully and check claims.
Biotech sites serve four audiences at once: scientists, investors, potential partners and recruits. Each reads differently, and copy that satisfies one often fails another.
On one site
Claims that survive review
Publication libraries
Accessibility standard
Clear stage-by-stage programme information, editable by your team as milestones change.
Searchable and filterable with correct citation and DOI links — heavily used, usually poorly built.
Materials, filings and updates presented credibly for a financially literate audience.
Technology and platform pages aimed at business development rather than at consumers.
Hiring pages and application flows for organisations recruiting scientific staff continuously.
Content models that make the precise, approved version the easy one to publish.
Because overstating a programme stage or a claim is a regulatory and investor-relations problem, not just weak marketing.
We build what your regulatory and medical affairs teams specify and structure content so review is efficient. We are not qualified to advise on what claims are permissible and will not pretend to be.
For internal systems we implement the technical controls it describes — audit trails, access control, record integrity. Validation and qualification are a formal process that sits with your quality function.
Yes. Programme stages, publications and content are modelled in a CMS so updates around a milestone take minutes rather than a development cycle.
Yes, and the needs differ — usually a credible corporate site and investor content rather than the broader platform a commercial-stage company requires.
Indicative ranges in USD. Every engagement is quoted to a written scope before work starts, so the number you approve is the number you pay.
$8,000 – $25,000
6–12 weeks
Best for: Pipeline, publications and investor content
$20,000 – $60,000
10–20 weeks
Best for: Research and operations software
from $1,200 / month
Ongoing
Best for: Sites updated around milestones
How we think about this work, in more depth.
Biotech
A 30-minute call, then a written proposal with scope, price and timeline within two to three working days. No retainer required to get a real number, and no obligation if the answer is that we are not the right fit.